Cargando…

Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus

BACKGROUND: Nalfurafine (Remitch(®), Toray Industries, Inc.) is a selective κ-receptor agonist approved in Japan for the improvement of pruritus in patients with chronic liver diseases (only when existing treatments bring insufficient efficacy) in May 2015. METHODS: A post-marketing Specific Drug Us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshitani, Hiroshi, Ito, Junko, Kozono, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075016/ https://www.ncbi.nlm.nih.gov/pubmed/35530746 http://dx.doi.org/10.2147/HMER.S352775

Ejemplares similares

Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch(®) capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus
por: Kozono, Hideki, et al.
Publicado: (2018)

Nalfurafine hydrochloride to treat pruritus: a review
por: Inui, Shigeki
Publicado: (2015)

Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients
por: Zhang, Ping, et al.
Publicado: (2023)

Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride
por: Yoshikawa, Shuhei, et al.
Publicado: (2021)

Poly[μ(2)-aqua-(μ(3)-2,5-dichlorobenzenesulfonato)sodium]
por: Al-Dajani, Mohammad T. M., et al.
Publicado: (2010)

Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial
por: Gattás, Daniele S. M. B., et al.
Publicado: (2020)

catena-Poly[[penta-μ-benzoato-μ-chlorido-dioxanedineodymium(III)] dioxane 2.5-solvate]
por: Bertke, Jeffrey A., et al.
Publicado: (2012)

Poly[di-μ-aqua-μ(4)-(pyrazine-2,5-dicarboxylato)-dilithium(I)]
por: Starosta, Wojciech, et al.
Publicado: (2010)

catena-Poly[diimidazolium [bis(μ-pyridine-2,5-dicarboxylato)bis[diaquapraseodymate(III)]]-bis(μ-pyridine-2,5-dicarboxylato)]
por: Zhang, Wenjun, et al.
Publicado: (2011)

Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial protocol
por: Gattás, Daniele Sofia Moraes Barros, et al.
Publicado: (2018)

Poly[tetraaquabis(μ(4)-thiophene-2,5-dicarboxylato)(μ(2)-thiophene-2,5-dicarboxylato)dieuropium(III)]
por: Du, Xi-Gang, et al.
Publicado: (2012)

Prognostic impact of troponin > 0.2 μg/ml and < 0.5 μg/m in UA/NSTIMI
por: Gomes de Sá, S, et al.
Publicado: (2003)

Clinical Effect and Safety Analysis of 2.5 μg/kg DEX Nasal Drop in Child Undergoing Ultrasound Examination
por: Tu, Haiya, et al.
Publicado: (2022)

Association of uremic pruritus in hemodialysis patients with the number of days of high mean 24-hour particulate matter with a diameter of <2.5 μm
por: Liu, Ming-Hui, et al.
Publicado: (2017)

catena-Poly[[[diaquairon(II)]-μ-pyridine-2,5-dicarboxylato-[tetraaquairon(II)]-μ-pyridine-2,5-dicarboxylato] tetrahydrate]
por: Xu, Hai-Yun, et al.
Publicado: (2008)

Poly[[aqua-μ(3)-picolinato-μ(2)-picolinato-dipicolinatopotassium(I)terbium(III)] 2.5-hydrate]
por: Cunha-Silva, Luís, et al.
Publicado: (2008)

Tetra-μ-2,5-difluorobenzoato-bis[(2,2′-bipyridine)(2,5-difluorobenzoato)gadolinium(III)]
por: Li, Sheng, et al.
Publicado: (2008)

Retracted: Clinical Effect and Safety Analysis of 2.5 μg/kg DEX Nasal Drop in Child Undergoing Ultrasound Examination
por: Healthcare Engineering, Journal of
Publicado: (2023)

Poly[[tri-μ(3)-hydroxido-tris(μ(4)-pyridine-2,5-dicarboxylato)trineodymium(III)] monohydrate]
por: Zhang, Qing, et al.
Publicado: (2012)

catena-Poly[[[diaquathulium(III)]-μ-6-carboxynicotinato-μ-pyridine-2,5-dicarboxylato] dihydrate]
por: Li, Sheng, et al.
Publicado: (2009)

catena-Poly[[[diaquaterbium(III)]-μ-6-carboxynicotinato-μ-pyridine-2,5-dicarboxylato] dihydrate]
por: Li, Sheng, et al.
Publicado: (2009)

A Prospective Randomized Trial of Ropivacaine 5 mg with Sufentanil 2.5 μg as a Test Dose for Detecting Epidural and Intrathecal Injection in Obstetric Patients
por: Li, Yue, et al.
Publicado: (2022)

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
por: Kawano, Tadamichi, et al.
Publicado: (2022)

Poly[tetra-n-butylammonium [(μ(5)-benzene-1,3,5-tricarboxylato)(μ(4)-benzene-1,3,5-tricarboxylato)-μ(3)-hydroxido-trizincate] 0.25-hydrate]
por: Zhu, Xiao-Hong, et al.
Publicado: (2011)

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD
por: Feldman, Gregory, et al.
Publicado: (2016)

Poly[piperazinediium [aquabis(μ-pyridine-2,5-dicarboxylato)zincate] dihydrate]
por: Aghabozorg, Hossein, et al.
Publicado: (2007)

Mid-infrared optical frequency combs at 2.5 μm based on crystalline microresonators
por: Wang, C. Y., et al.
Publicado: (2013)

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD
por: Siler, Thomas M, et al.
Publicado: (2016)

Poly[aqua(dimethyl sulfoxide)(μ(4)-pyridine-2,5-dicarboxylato)calcium(II)]
por: Pasdar, Hoda, et al.
Publicado: (2011)

Effect of Exposure to 2.5 μm Indoor Particulate Matter on Adult Lung Function in Jakarta
por: Pramitha, Eky, et al.
Publicado: (2019)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Temperature-Independent Current Dispersion in 0.15 μm AlGaN/GaN HEMTs for 5G Applications
por: Zagni, Nicolò, et al.
Publicado: (2022)

Intractable Pruritus Caused by Pigeon Mites
por: Chauhan, Vivek, et al.
Publicado: (2015)

catena-Poly[[aquanickel(II)]-μ-pyridine-2,6-dicarboxylato-[aquanickel(II)]-μ-2,5-di-4-pyridyl-1,3,4-thiadiazole]
por: Zhang, Xin-Yan
Publicado: (2009)

catena-Poly[[trimethyltin(IV)]-μ-2,5-difluorobenzoato-κ(2) O:O′]
por: Wen, Liyuan, et al.
Publicado: (2008)

Microarrays for Microbes: the BμG@S Approach
por: Hinds, Jason, et al.
Publicado: (2002)

Comparative analysis of efficacy of lignocaine 1.5 mg/kg and two different doses of dexmedetomidine (0.5 μg/kg and 1 μg/kg) in attenuating the hemodynamic pressure response to laryngoscopy and intubation
por: Gulabani, Michell, et al.
Publicado: (2015)

Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)
por: Bitzer, Johannes, et al.
Publicado: (2015)

Experiments on MEMS Integration in 0.25 μm CMOS Process
por: Michalik, Piotr, et al.
Publicado: (2018)

Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section
por: Cohen, Shaul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_51kla7m1e8ikgi36cd7n3vb24c